scispace - formally typeset
Journal ArticleDOI

Absence of mutations in superoxide dismutase and catalase genes in patients with Parkinson's disease

TLDR
Parkinson's disease is not caused by mutations in the genes of these three detoxifying enzymes, and the exon 9 variant in the catalase gene in the one family with PD is most likely a silent mutation and not the genetic cause of PD in this family.
Abstract
Background: Parkinson's disease (PD) is an adultonset, neurodegenerative disorder characterized by a selective loss of the dopaminergic cells of the substantia nigra and by progressive motor decline. Studies have shown aberrant oxidative stress metabolism within the substantia nigra and other dopaminergic regions of the brain in patients with PD. Objective: To screen the genes of three free radical detoxifying enzymes—copper/zinc superoxide dismutase, manganese superoxide dismutase, and catalase—for mutations in patients with PD. Patients and Methods: A total of 107 unrelated patients with PD from two PD populations (familial and sporadic) were screened for mutations in the genes of copper/zinc superoxide dismutase, manganese superoxide dismutase, and catalase by single-strand conformation analysis. The diagnosis of PD was based on the clinical observations of resting tremor, rigidity, and bradykinesia. Results: No mutations were identified. However, we did identify an amino acid substitution (glycine to aspartic acid) in exon 9 of the catalase gene in one patient; decreased red blood cell catalase activity was observed in this patient. Conclusion: Parkinson's disease is not caused by mutations in the genes of these three detoxifying enzymes. The exon 9 variant in the catalase gene in the one family with PD is most likely a silent mutation and not the genetic cause of PD in this family.

read more

Citations
More filters
Journal ArticleDOI

Neuroprotective strategies in Parkinson's disease : an update on progress.

TL;DR: In spite of the extensive studies performed on postmortem substantia nigra from Parkinson’s disease patients, these studies have demonstrated that, at the time of death, a cascade of events had been initiated that may contribute to the demise of the melanin-containing nigro-striatal dopamine neurons.
Journal ArticleDOI

Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features.

TL;DR: Investigations in Australia, subsequent to the publication of the paper by Cleveland et al ,2identified the mutation in this family as His43Arg, not Gly37Arg, and the mutation was identified as H43R by investigations in Australia.
Journal ArticleDOI

Genes and parkinsonism.

TL;DR: The molecular genetics of Parkinson's disease as currently understood is described to help explain the pathways that underlie neurodegeneration.
Journal ArticleDOI

Peroxisomal Hydrogen Peroxide Metabolism and Signaling in Health and Disease

TL;DR: The focus of this review is to comprehensively evaluate the evidence that peroxisomes, organelles best known for their role in cellular lipid metabolism, also serve as hubs in the H2O2 signaling network.
Journal ArticleDOI

Etiology of Parkinson's Disease

TL;DR: Genetic factors, infectious and immunological abnormalities, the effects of ageing, toxins, toxins (endogenous as well as exogenous) and other environmental factors may all contribute to the development of Parkinson's disease.
References
More filters
Journal ArticleDOI

DNA sequencing with chain-terminating inhibitors

TL;DR: A new method for determining nucleotide sequences in DNA is described, which makes use of the 2',3'-dideoxy and arabinon nucleoside analogues of the normal deoxynucleoside triphosphates, which act as specific chain-terminating inhibitors of DNA polymerase.
Journal ArticleDOI

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

TL;DR: Tight genetic linkage between FALS and a gene that encodes a cytosolic, Cu/Zn-binding superoxide dismutase (SOD1), a homodimeric metalloenzyme that catalyzes the dismutation of the toxic superoxide anion O–2 to O2 and H2O2 is reported.
Journal ArticleDOI

Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.

TL;DR: Reduced glutathione and the shift of the iron (II)/iron (III) ratio in favor of iron ( III) suggest that these changes might contribute to pathophysiological processes underlying PD.
Journal ArticleDOI

Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease

TL;DR: The results may indicate that an increased level of lipid peroxidation continues to occur in the parkinsonian nigra up to the time of death, perhaps because of continued exposure to excess free radicals derived from some endogenous or exogenous neurotoxic species.
Related Papers (5)